Current treatment paradigms and emerging therapies for NAFLD/NASH
Non-alcoholic fatty liver disease (NAFLD) is one the fastest emerging manifestations of the metabolic syndrome worldwide. Non-alcoholic steatohepatitis (NASH), the progressive form of NAFLD, may culminate into cirrhosis and hepatocellular cancer (HCC) and is presently a leading cause of liver transp...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Revisão |
| Jezik: | angleščina |
| Izdano: |
2020
|
| Online dostop: | https://doi.org/10.2741/4892 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|